Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 22.5.2017 | EN | Official Journal of the European Union | C 161/26 |

---

Judgment of the General Court of 6 April 2017 — Azanta v EUIPO — Novartis (NIMORAL)

(Case T-49/16)[(1)](#ntr1-C_2017161EN.01002601-E0001)

((EU trade mark - Opposition proceedings - Application for the EU word mark NIMORAL - Earlier EU word mark NEORAL - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009))

(2017/C 161/36)

Language of the case: English

Parties

Applicant: Azanta A/S (Hellerup, Denmark) (represented by: M. Hoffgaard Rasmussen, lawyer)

Defendant: European Union Intellectual Property Office (represented by: J. Ivanauskas, Agent)

Other parties to the proceedings before the Board of Appeal of EUIPO: Novartis AG (Basel, Switzerland)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 1 December 2015 (Case R 634/2015-4), relating to opposition proceedings between Novartis and Azanta.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Azanta A/S to pay the costs. |

---

[Top](#document1)